Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2025
Filed with BSE · · 9 pages · English
Office: 903-909. 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, India Telephone no.: 011-27355742, 71239900(44 Lines), CIN: L74999RJ1992PLC013387 ____________________________________________________________________________________ 12th February, 2026 12 th February, 2026 Sub: Outcome of Board Meeting held on February 12, 2026 Please find enclosed, unaudited financial result (Standalo
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Feb 10 2026
- Announcement Regarding New ISIN Activation Letter From Depositories For Sub-Division Of Equity Share Of The Company
- Titan Biotech Limited Press Release Feb 06 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Feb 05 2026
Later from Titan Biotech
- Titan Biotech Limited Press Release Feb 12 2026
- Titan Biotech Limited Press Release Feb 13 2026
- Closure of Trading Window
- Titan Biotech Limited Press Release Mar 26 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech